Washington, DC — In a letter to the heads of the U.S. Food & Drug Administration (FDA), the Centers for Disease Control and Prevention, and the U.S. Department of Health and Human Services, Americans for Safe Access calls for the...
Read moreWashington, DC -- Americans for Safe Access (ASA) has released The Medical Cannabis Patient’s Guide for U.S. Travel in conjunction with the start of Labor Day weekend. This guide will help traveling patients understand the laws regarding access to cannabis...
Read moreWashington, DC -- According to a press release by the U.S. Department of Justice on Monday, the Drug Enforcement Administration has filed a notice in the Federal Register of its intention to promulgate regulations that govern the growing of cannabis...
Read moreWashington, DC -- Americans for Safe Access (ASA) has released its 2019 report card titled, “2019 State of the States Report: An Analysis of Medical Cannabis Access in the United States” in conjunction with the start of the National Conference...
Read moreWashington, DC -- Americans for Safe Access (ASA) announced today a partnership to provide continuing medical education (CME) credits for medical professionals through their Cannabis Care Certification (CCC) website. The CCC Comprehensive Medical Marijuana Curriculum, created by The Answer Page, Inc....
Read moreOlney, MT – Americans for Safe Access (ASA) is pleased to announce that Stillwater Laboratory of Olney, MT has been certified for laboratory analysis of cannabis products under ASA’s Patient Focused Certification (PFC) program and ISO/IEC 17025 through a dual accreditation program conducted with...
Read moreWashington, D.C. - Americans for Safe Access (ASA), the leading advocacy organization dedicated to ensuring safe and legal access to cannabis (marijuana) for therapeutic use and research, and Aurelius Data, Inc.(AD), the premier patient perception big data company, and announced...
Read moreContact: Reenal Doshi, [email protected], (202) 857-4272 x. 4 Washington, DC — Americans for Safe Access (ASA) has released the Patient’s Guide to CBD in response to the May 31 public hearing at the Federal Drug Administration (FDA) regarding products containing...
Read moreContact: Sean Khalepari | [email protected] Washington, DC — On May 31, 2019 the FDA will be holding a public hearing to collect scientific information and data on cannabis and cannabis derived products. In holding this hearing, the FDA is seeking public...
Read moreContact: David Mangone | [email protected] Law Passed Allowing Doctors to Recommend Cannabis Instead of Opioids Washington, DC — Governor Jared Polis has signed into law SB-013, a bill that allows Colorado physicians to authorize individuals to use medical cannabis instead...
Read moreShare this page
ASA serves our mission with the help and support of many organizations and businesses. Click here to learn more about these amazing allies!
